Schedule 13G ownership disclosure

ORIC Pharmaceuticals Inc

Common Stock, $0.0001 par value per share · CUSIP: 68622P109

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Nextech Crossover I GP S.a. r.l.

    Shares: 7,162,637.00 · Class: 8.4%

  • Nextech Crossover I SCSp

    Shares: 7,162,637.00 · Class: 8.4%

  • Ian Charoub

    Shares: 7,162,637.00 · Class: 8.4%

  • Costas Constantinides

    Shares: 7,162,637.00 · Class: 8.4%

  • Rocco Sgobbo

    Shares: 7,162,637.00 · Class: 8.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-021933
Form type
SCHEDULE 13G/A
Filer
Nextech Crossover I GP S.a r.l.
CIK
CIK 1916761
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub